GeoLinks wins federal broadband contract, plans ‘massive growth’
For the past few years, GeoLinks’ goal as an internet service provider has been bringing connectivity to rural areas in California not prioritized by the bigger providers like Verizon or AT&T. It recently got a big boost in that effort in the form of a $234.9 million federal contract.
Read More →Westlake Village BioPartners puts $500 million into new venture funds
Westlake Village BioPartners, a venture capital firm focused on biotech startups in the Conejo Valley and the rest of greater Los Angeles, launched two new funds Dec. 15 worth a total of $500 million. The first fund is $70 million and will be used for Series B or later financing into companies that Westlake Village Read More →
Read More →AeroVironment expands into ground robotics with German acquisition
AeroVironment, an aerial drone company based in Simi Valley, reached an agreement Dec. 8 to acquire Telerob, a German robotics company, in a deal worth approximately $45.4 million in cash.
Read More →GeoLinks wins $235M federal broadband contract
GeoLinks, an internet service provider based in Camarillo, has won a bid worth $234.9 million from the federal government to bring high-speed broadband to underserved homes and businesses. According to a statement released Dec. 7 by GeoLinks, the contract comes from the Federal Communication Commission’s Rural Digital Opportunity Fund, which is spending up to $20.4 Read More →
Read More →Simi Valley’s AeroVironment buys German robotics firm for $45M
AeroVironment, an aerial drone company based in Simi Valley, reached an agreement Dec. 8 to acquire Telerob, a German robotics company, in a deal worth approximately $45.4 million in cash. AeroVironment also released its second quarter 2021 earnings on Dec. 8, revealing an increase in revenue, but a 71% drop in earnings from the previous Read More →
Read More →MannKind makes $12.5M pharma buy
MannKind Corp., a biotech company based in Westlake Village, announced Dec. 7 that it has acquired a QrumPharma, a privately held biotech company, in a $12.5 million deal. MannKind has purchased all outstanding capital stock of QrumPharma for $3.5 million in cash and just over 3 million shares of MannKind common stock. At MannKind’s stock Read More →
Read More →UV light startup helps restaurants go antiviral
As a result of the COVID-19 pandemic, owners of all sorts of businesses are looking at an option for disinfecting surfaces that has long been dismissed as too expensive to use outside of hospitals: UV-C technology.
Read More →
Sponsored content:
2015-2016 Giving Guide
